Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Female Sex, Age, and Unfavorable Response to Tumor Necrosis Factor Inhibitors in Patients With Axial Spondyloarthritis: Results of Statistical and Artificial Intelligence-Based Data Analyses of a National Multicenter Prospective Registry.
Fernández-Carballido C, Sanchez-Piedra C, Valls R, Garg K, Sánchez-Alonso F, Artigas L, Mas JM, Jovaní V, Manrique S, Campos C, Freire M, Martínez-González O, Castrejón I, Perella C, Coma M, van der Horst-Bruinsma IE. Fernández-Carballido C, et al. Among authors: mas jm. Arthritis Care Res (Hoboken). 2023 Jan;75(1):115-124. doi: 10.1002/acr.25048. Epub 2022 Dec 9. Arthritis Care Res (Hoboken). 2023. PMID: 36278846
A decision support system based on artificial intelligence and systems biology for the simulation of pancreatic cancer patient status.
Junet V, Matos-Filipe P, García-Illarramendi JM, Ramírez E, Oliva B, Farrés J, Daura X, Mas JM, Morales R. Junet V, et al. Among authors: mas jm. CPT Pharmacometrics Syst Pharmacol. 2023 Jul;12(7):916-928. doi: 10.1002/psp4.12961. Epub 2023 Mar 31. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 37002678 Free PMC article.
The LEGACy study: a European and Latin American consortium to identify risk factors and molecular phenotypes in gastric cancer to improve prevention strategies and personalized clinical decision making globally.
van Schooten TS, Derks S, Jiménez-Martí E, Carneiro F, Figueiredo C, Ruiz E, Alsina M, Molero C, Garrido M, Riquelme A, Caballero C, Lezcano E, O'Connor JM, Esteso F, Farrés J, Mas JM, Lordick F, Vogt J, Cardone A, Girvalaki C, Cervantes A, Fleitas T; members of LEGACy consortium. van Schooten TS, et al. Among authors: mas jm. BMC Cancer. 2022 Jun 13;22(1):646. doi: 10.1186/s12885-022-09689-9. BMC Cancer. 2022. PMID: 35692051 Free PMC article.
Identification of the most vulnerable populations in the psychosocial sphere: a cross-sectional study conducted in Catalonia during the strict lockdown imposed against the COVID-19 pandemic.
Farrés J, Ruiz JL, Mas JM, Arias L, Sarrias MR, Armengol C, Cardona PJ, Munoz-Moreno JA, Vilaplana M, Arranz B, Usall J, Serrano-Blanco A, Vilaplana C. Farrés J, et al. Among authors: mas jm. BMJ Open. 2021 Nov 26;11(11):e052140. doi: 10.1136/bmjopen-2021-052140. BMJ Open. 2021. PMID: 34836903 Free PMC article.
Head to head evaluation of second generation ALK inhibitors brigatinib and alectinib as first-line treatment for ALK+ NSCLC using an in silico systems biology-based approach.
Carcereny E, Fernández-Nistal A, López A, Montoto C, Naves A, Segú-Vergés C, Coma M, Jorba G, Oliva B, Mas JM. Carcereny E, et al. Among authors: mas jm. Oncotarget. 2021 Feb 16;12(4):316-332. doi: 10.18632/oncotarget.27875. eCollection 2021 Feb 16. Oncotarget. 2021. PMID: 33659043 Free PMC article.
41 results